A new prognostic model including platelet/lymphocyte ratio and International Prognostic Score 3 for freedom from progression in patients with previously untreated advanced classical Hodgkin lymphoma.
Yunxia TaoHaizhu ChenYu ZhouXiaohu HeYan QinPeng LiuShengyu ZhouJianliang YangLiqiang ZhouChanggong ZhangSheng YangLin GuiYuan-Kai ShiPublished in: Asia-Pacific journal of clinical oncology (2022)
The IPSPLR is an easily used tool for FFP prediction for newly diagnosed advanced cHL. Validation of this tool in other large datasets is needed.